Advanced Search

Home > Journals > Minerva Ginecologica > Past Issues > Minerva Ginecologica 2016 October;68(5) > Minerva Ginecologica 2016 October;68(5):517-35

ISSUES AND ARTICLES   MOST READ   eTOC

CURRENT ISSUEMINERVA GINECOLOGICA

A Journal on Obstetrics and Gynecology

Indexed/Abstracted in: EMBASE, PubMed/MEDLINE, Scopus, Emerging Sources Citation Index

Frequency: Bi-Monthly

ISSN 0026-4784

Online ISSN 1827-1650

 

Minerva Ginecologica 2016 October;68(5):517-35

HEREDITARY GENITAL AND BREAST CANCER 

    REVIEWS

Pharmacoprevention for hereditary breast and ovarian cancer

Massimiliano CAZZANIGA, Bernardo BONANNI

Division of Cancer Prevention and Genetics, European Institute of Oncology, Milan, Italy

Hereditary breast and ovarian cancer (HBOC) syndrome is an important women’s health condition characterized by an increased susceptibility to the development of cancer, in particular breast and ovarian neoplasms, and is caused by an inherited germline genetic mutation in one or both tumor suppressor genes named BRCA1 and BRCA2. This monographic issue provides an update on our knowledge of this syndrome with particular emphasis on the risk reduction strategies through a pharmacopreventive approach.

language: English


FULL TEXT  REPRINTS

top of page